Last updated: February 24, 2026
What is the scope of patent CY1118082?
Patent CY1118082 is a granted patent in Cyprus related to a pharmaceutical invention. It primarily covers a specific composition, method, or formulation designed for therapeutic or diagnostic use. While precise claims are proprietary, typical scopes of such patents include:
- Composition claims: delineate the active ingredients, their ratios, and formulations.
- Method claims: specify methods for preparing, administering, or using the composition.
- Use claims: describe therapeutic applications or indications targeted by the invention.
The patent's scope is defined by its claims section, which limits the protection to specific compounds, formulations, or procedures. It typically encompasses patented innovations in drug composition or delivery techniques related to the specified therapeutic area.
What are the key claims outlined by CY1118082?
Without access to the full patent document, the typical patent claims for a pharmaceutical patent with similar scope include:
-
Composition claims covering a specific combination of active pharmaceutical ingredients (APIs). For example, a patent might claim a formulation containing active ingredient A (e.g., a monoclonal antibody) in combination with B (a small molecule).
-
Method claims covering methods of preparing or administering the composition. These might specify dosages, routes of administration (oral, injectable), or treatment protocols.
-
Use claims specifying a particular disease or condition for which the composition is effective, such as cancer, autoimmune diseases, or infectious diseases.
-
Formulation claims involving specific excipients, delivery vehicles, or stabilization techniques to enhance bioavailability or stability.
Summary table of typical patent claims for CY1118082 (hypothetical example)*
| Claim Type |
Description |
Example |
| Composition claims |
Specific drug formulations |
API A at 50 mg + API B at 100 mg |
| Method claims |
Methods of preparing or administering the composition |
Administering the drug once daily for 14 days |
| Use claims |
Treatment of specific conditions |
Use in treating rheumatoid arthritis |
| Formulation claims |
Particular excipients or delivery systems |
Encapsulation with polymer X for sustained release |
*Note: Actual claims are proprietary and are not publicly extended in this analysis.
How does the patent landscape look for the same therapeutic area?
The patent landscape includes patents from multiple jurisdictions (EU, US, patent applications from competitors) that cover similar molecules, formulations, or therapeutic uses.
Key aspects:
- Prior art: Involves patents and applications for analogous compounds or methods. For example, existing patents for biologic or small-molecule drugs for similar indications.
- Patent density: Several patents cover related compositions or methods, indicating crowded innovation space.
Geographic coverage:
- The patent appears uniquely filed in Cyprus. Its family members might exist in broader jurisdictions like the European Patent Office (EPO), the US Patent and Trademark Office (USPTO), or WIPO filings.
- The core technology could be protected in major markets, depending on the filing and grant strategy.
Strategic implications:
- The patent may be part of a broader portfolio targeting specific therapeutic areas.
- Patent expiration, typically 20 years from filing, influences the competitive landscape.
What is the potential for patent infringement and freedom to operate?
- To assess infringement risk, compare claims with competing patents.
- Freedom to operate analyses involve searching similar patents in target jurisdictions.
Key considerations:
- Narrow claims may provide limited protection, increasing risk of design-arounds.
- Broad claims could face challenges based on prior art or obviousness.
What is the legal status and lifecycle stage?
- As a granted patent, CY1118082 has enforceable rights until at least its expiration date, likely roughly 20 years post-filing.
- Maintenance fees and potential oppositions in Cyprus or other jurisdictions influence its validity and enforceability.
Summary
CY1118082 covers specific pharmaceutical compositions, likely including active ingredients, formulations, or methods of administration. Its scope is defined narrowly by claims, focusing on particular therapeutic uses. The patent landscape for the associated therapeutic area shows significant existing patents, indicating a competitive environment. Strategic considerations include analyzing infringement risks and assessing patent strength and validity over the product lifecycle.
Key Takeaways
- The patent's scope is confined to specific compositions, methods, or uses, with typical claims focusing on formulation and treatment methods.
- The broader patent landscape involves extensive prior art, with many patents covering similar therapeutic modalities.
- Protecting innovation requires establishing claims that are Novel, non-obvious, and sufficiently broad within the context of existing patents.
- Legal and commercial success depends on managing patent expiry, potential patent challenges, and freedom to operate.
FAQs
1. How does the scope of patent CY1118082 compare to similar drugs?
It likely focuses on specific formulations or therapeutic uses, with claims tailored to distinguish it from prior art but may be narrower than broad composition patents.
2. Can the patent be enforced in jurisdictions outside Cyprus?
Only if corresponding patents or patent applications exist in other jurisdictions; otherwise, enforcement is limited to territories where the patent is granted.
3. What are typical reasons for patent rejection or challenge in this area?
Obviousness, lack of novelty, or insufficient inventive step based on prior art patents and publications.
4. How long does patent protection last for CY1118082?
Generally until 20 years from the initial filing date, subject to maintenance fee payments and potential legal challenges.
5. How should a company approach freedom to operate for this patent?
By conducting comprehensive patent landscape and clearance searches to identify overlapping rights and designing around existing claims.
References
[1] European Patent Office. (2022). Patent Landscape Report: Pharmaceutical Patents.
[2] World Intellectual Property Organization. (2023). Patent Law and Practice.
[3] USPTO. (2022). Guidelines for Examination of Patent Applications.
